Exephin 1 gm/vial (IV Injection)
1 gm vial: ৳ 190.00
Medicine Details
Category | Details |
---|---|
Generic | Ceftriaxone sodium |
Company | Incepta pharmaceuticals ltd |
Also available as |
Indications
- Lower respiratory tract infections
- Acute Bacterial Otitis Media
- Skin and skin structure infections
- Urinary tract infections
- Gonorrhea
- Bacterial Septicemia
- Bone and joint infections
- Meningitis
- Prevention of postoperative infections
- Perioperative prophylaxis of infections associated with surgery
Pharmacology
- 3rd generation broad-spectrum parenteral cephalosporin antibiotic
- Potent bactericidal activity against a wide range of Gram-positive and Gram-negative organisms
- Interferes with the synthesis of the bacterial cell wall
- High stability in the presence of beta lactamases
- Long plasma elimination half-life of about 6 to 9 hours
- Not metabolized in the body
- Highly protein bound (95%)
Dosage
- Usual adult dose of 1 to 2 gm by intravenous or intramuscular administration once a day
- Variations in dosage for different infections and age groups
- Duration of therapy: 4 to 14 days; longer therapy may be required in complicated infections
Administration
- Preparation of solutions for intramuscular / intravenous injections
- Injection should be administered over 2-4 minutes
- Freshly reconstituted solution recommended for use
Interaction
- No reported drug interactions
Contraindications
- Not to be given to patients with a history of hypersensitivity to cephalosporin antibiotics
Side Effects
- Gastro-intestinal effects including diarrhea, nausea, vomiting, stomatitis, and glossitis
- Cutaneous reactions including rash, pruritus, urticaria, edema, and erythema multiforme
- Hematologic reactions including eosinophilia, thrombocytopenia, leucopenia, anemia, and neutropenia
- Hepatic reactions including elevations of SGOT or SGPT, bilirubinemia
- CNS reactions including nervousness, confusion, sleep disturbances, headache, hyperactivity, convulsion, hypertonia, and dizziness
- Rare occurrence of local phlebitis following intravenous administration
Pregnancy & Lactation
- Safety in human pregnancy not established
- Caution advised when administered to a lactating mother
Precautions & Warnings
- Anaphylactic shock may occur
- Regular blood picture checks recommended during prolonged treatment
Use in Special Populations
- Not to be given to premature and newborn neonates (up to 28 days of age)
Overdose Effects
- No specific antidote
- Treatment should be symptomatic
Therapeutic Class
- Third generation Cephalosporins
Storage Conditions
- Store in a cool, dry place (below 30°C), away from light & moisture
- Keep out of the reach of children
Related Brands
- G-Ceftriax 250 mg/vial (IM Injection) - gonoshasthaya-pharma-ltd
- G-Ceftriax 500 mg/vial (IM Injection) - gonoshasthaya-pharma-ltd
- G-Ceftriax 1 gm/vial (IM Injection) - gonoshasthaya-pharma-ltd
- G-Ceftriax 250 mg/vial (IV Injection) - gonoshasthaya-pharma-ltd
- G-Ceftriax 500 mg/vial (IV Injection) - gonoshasthaya-pharma-ltd